OncoMed Pharmaceuticals Inc Retained Earnings
OncoMed Pharmaceuticals Inc had Retained Earnings of -$361.79 million as of 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2019-03-07
- 2018-12-31: Retained Earnings (Accumulated Deficit) -$361.79M.
- 2018-09-30: Retained Earnings (Accumulated Deficit) -$357.12M.
- 2018-06-30: Retained Earnings (Accumulated Deficit) -$363.24M.
- 2018-03-31: Retained Earnings (Accumulated Deficit) -$359.26M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2018-12-31 | -$361.79M 10-K · filed 2019-03-07 |
| 2018-09-30 | -$357.12M 10-Q · filed 2018-11-01 |
| 2018-06-30 | -$363.24M 10-Q · filed 2018-08-02 |
| 2018-03-31 | -$359.26M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$452.01M 10-K · filed 2019-03-07 |
| 2017-09-30 | -$461.47M 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$450.78M 10-Q · filed 2017-08-02 |
| 2017-03-31 | -$435.55M 10-Q · filed 2017-05-08 |
| 2016-12-31 | -$412.94M 10-K · filed 2018-03-09 |
| 2016-09-30 | -$390.61M 10-Q · filed 2016-11-01 |
| 2016-06-30 | -$364.75M 10-Q · filed 2016-08-09 |
| 2016-03-31 | -$337.06M 10-Q · filed 2016-05-05 |
| 2015-12-31 | -$309.84M 10-K · filed 2017-03-09 |
| 2015-09-30 | -$285.06M 10-Q · filed 2015-11-05 |
| 2015-06-30 | -$260.58M 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$238.97M 10-Q · filed 2015-05-07 |
| 2014-12-31 | -$224.44M 10-K · filed 2016-03-10 |
| 2014-09-30 | -$209.38M 10-Q · filed 2014-11-04 |
| 2014-06-30 | -$203.89M 10-Q · filed 2014-08-07 |
| 2014-03-31 | -$188.30M 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$174.43M 10-K · filed 2015-03-12 |
| 2013-09-30 | -$170.08M 10-Q · filed 2013-11-13 |
| 2013-06-30 | -$166.60M 10-Q · filed 2013-09-03 |
| 2012-12-31 | -$148.35M 10-K · filed 2014-03-18 |